NASDAQ:CME CME Group (CME) Stock Price, News & Analysis $291.23 +1.94 (+0.67%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$290.60 -0.63 (-0.22%) As of 05/22/2026 07:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About CME Group Stock (NASDAQ:CME) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get CME Group alerts:Sign Up Key Stats Today's Range$289.10▼$293.0950-Day Range$281.25▼$313.8352-Week Range$257.17▼$329.16Volume1.44 million shsAverage Volume2.28 million shsMarket Capitalization$105.53 billionP/E Ratio24.85Dividend Yield1.79%Price Target$305.29Consensus RatingModerate Buy Company Overview CME Group Inc. is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants. The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics. These capabilities support price discovery and risk transfer while reducing counterparty credit risk through centralized clearing and margining. CME Group also provides post-trade services, trade reporting, and various risk-management and regulatory reporting tools for market participants and intermediaries. CME Group was created through the consolidation of major U.S. derivatives exchanges, notably through the merger that produced the modern entity in 2007 and subsequent strategic acquisitions, including the integration of NYMEX in 2008. Headquartered in Chicago, the company operates on a global scale with trading and distribution networks that reach market participants across the Americas, Europe and Asia. Leadership has emphasized electronic trading growth, clearing robustness and product expansion to serve evolving client needs; Terry Duffy has served as chairman and chief executive officer. As an operator of regulated exchanges and a systemically important central counterparty, CME Group plays a central role in global financial markets by facilitating hedging, investment and price discovery for a wide range of market participants while maintaining infrastructure intended to promote market integrity and operational resilience.AI Generated. May Contain Errors. Read More CME Group Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks81st Percentile Overall ScoreCME MarketRank™: CME Group scored higher than 81% of companies evaluated by MarketBeat, and ranked 309th out of 881 stocks in the finance sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.7 / 5Analyst RatingModerate Buy Consensus RatingCME Group has received a consensus rating of Moderate Buy. The company's average rating score is 2.56, and is based on 2 strong buy ratings, 8 buy ratings, 6 hold ratings, and 2 sell ratings.Upside/DownsideThe consensus price target for CME Group is close to its current price, suggesting limited near-term upside or downside.Amount of Analyst CoverageCME Group has been the subject of 14 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about CME Group's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings Growth4.23% Earnings GrowthEarnings for CME Group are expected to grow by 4.23% in the coming year, from $12.28 to $12.80 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of CME Group is 24.85, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 44.79.Price to Earnings Ratio vs. SectorThe P/E ratio of CME Group is 24.85, which means that it is trading at a more expensive P/E ratio than the Finance sector average P/E ratio of about 23.96.Price to Earnings Growth RatioCME Group has a PEG Ratio of 3.52. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioCME Group has a P/B Ratio of 3.96. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about CME Group's valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.14% of the float of CME Group has been sold short.Short Interest Ratio / Days to CoverCME Group has a short interest ratio ("days to cover") of 1.68, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in CME Group has recently decreased by 14.58%, indicating that investor sentiment is improving significantly. Dividend2.5 / 5Dividend StrengthModerate Dividend YieldCME Group pays a meaningful dividend of 1.79%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthCME Group does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of CME Group is 44.37%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, CME Group will have a dividend payout ratio of 40.63% next year. This indicates that CME Group will be able to sustain or increase its dividend.Read more about CME Group's dividend. News and Social Media3.7 / 5News Sentiment0.87 News SentimentCME Group has a news sentiment score of 0.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.63 average news sentiment score of Finance companies.News Coverage This WeekMarketBeat has tracked 37 news articles for CME Group this week, compared to 12 articles on an average week.Search InterestOnly 4 people have searched for CME on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.MarketBeat Follows12 people have added CME Group to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days. Company Ownership1.4 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, CME Group insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $13,297,507.00 in company stock.Percentage Held by Insiders0.30% of the stock of CME Group is held by insiders.Percentage Held by Institutions87.75% of the stock of CME Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about CME Group's insider trading history. Receive CME Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CME Group and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CME Stock News HeadlinesAnalysts forecast a Bitcoin crash to the $60K level, revisiting 2026 lowMay 23 at 5:10 PM | cointelegraph.comSEC approves Nasdaq to list Bitcoin index options on the exchangeMay 23 at 5:50 AM | cointelegraph.comOne algorithm, 17 years, nearly 2,000% total returnsA physicist in Dublin claims his AI algorithm has beaten the market for 17 consecutive years - with nearly 2,000% total returns and only one losing year across two decades of crises. Porter Stansberry flew to Ireland to investigate the claim firsthand. The result is a new investigative documentary called 'Investigating Project Prophet,' available to stream now at no cost.May 24 at 1:00 AM | Porter & Company (Ad)Despite murky legal landscape, companies are undeterred in their prediction market investmentsMay 22 at 12:01 PM | cnbc.comXRP Futures Hit $62.87B at CME as Institutions Deepen ExposureMay 21 at 7:50 PM | news.bitcoin.comCME Group Awards Star Scholarships to Chicago Students Pursuing Four-Year DegreesMay 21 at 1:39 PM | prnewswire.comCME Group (CME) Serves as a Volatility ShieldMay 21 at 12:30 PM | insidermonkey.comCME Group (CME) Serves as a Volatility ShieldMay 21 at 11:10 AM | finance.yahoo.comSee More Headlines CME Stock Analysis - Frequently Asked Questions How have CME shares performed this year? CME Group's stock was trading at $273.08 on January 1st, 2026. Since then, CME stock has increased by 6.6% and is now trading at $291.23. How were CME Group's earnings last quarter? CME Group Inc. (NASDAQ:CME) announced its earnings results on Wednesday, April, 22nd. The financial services provider reported $3.36 earnings per share for the quarter, topping the consensus estimate of $3.11 by $0.25. The company's revenue for the quarter was up 14.5% on a year-over-year basis. Read the conference call transcript. How will CME Group's stock buyback program work? CME Group's Board of Directors authorized a stock buyback program on Thursday, December 5th 2024, which authorizes the company to buy back $3,000,000,000 in shares, according to EventVestor. This means that the company could reacquire up to 3.4% of its shares through open market purchases. Shares buyback programs are usually an indication that the company's board believes its shares are undervalued. Who are CME Group's major shareholders? CME Group's top institutional investors include Bank of New York Mellon Corp (1.33%), Bank of America Corp DE (1.11%), Royal Bank of Canada (0.81%) and Arrowstreet Capital Limited Partnership (0.71%). Insiders that own company stock include Terrence A Duffy, Bryan T Durkin, Larry G Gerdes, Julie Holzrichter, Hilda Harris Piell, Martin J Gepsman, Julie Winkler, Howard J Siegel, Elizabeth A Cook, Terry L Savage, Terry L Savage, Sunil Cutinho, Daniel R Glickman, Lynne Fitzpatrick, Timothy S Bitsberger, Timothy Francis Mccourt, Derek Sammann, Suzanne Sprague, Jonathan L Marcus, Charles P Carey, Daniel G Kaye, Phyllis M Lockett, Dennis Suskind, William R Shepard and Harold Eugene Jr Ford. View institutional ownership trends. How do I buy shares of CME Group? Shares of CME stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of CME Group own? Based on aggregate information from My MarketBeat watchlists, some other companies that CME Group investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), DiamondRock Hospitality (DRH) and Southern First Bancshares (SFST). Company Calendar Record date for 3/26 Dividend3/10/2026Ex-Dividend for 3/26 Dividend3/10/2026Dividend Payable3/26/2026Last Earnings4/22/2026Today5/24/2026Record date for 6/25 Dividend6/09/2026Ex-Dividend for 6/25 Dividend6/09/2026AGM 20266/09/2026Dividend Payable6/25/2026Next Earnings (Estimated)7/22/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (4d) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 As of 4 days ago, CME's financial health entered the Yellow zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorFinance Industry Securities Exchanges Sub-IndustrySpecialized Finance Current SymbolNASDAQ:CME CIK1156375 Webwww.cmegroup.com Phone(312) 930-1000Fax312-466-4410Employees3,875Year Founded1898Price Target and Rating Average Price Target for CME Group$305.29 High Price Target$353.00 Low Price Target$209.00 Potential Upside/Downside+4.8%Consensus RatingModerate Buy Rating Score (0-4)2.56 Research Coverage18 Analysts Profitability EPS (Trailing Twelve Months)$11.72 Trailing P/E Ratio24.85 Forward P/E Ratio23.72 P/E Growth3.52Net Income$4.07 billion Net Margins63.19% Pretax Margin82.81% Return on Equity15.42% Return on Assets2.24% Debt Debt-to-Equity Ratio0.13 Current Ratio1.02 Quick Ratio1.02 Sales & Book Value Annual Sales$6.52 billion Price / Sales16.18 Cash Flow$12.31 per share Price / Cash Flow23.66 Book Value$73.46 per share Price / Book3.96Miscellaneous Outstanding Shares362,360,000Free Float361,272,000Market Cap$105.53 billion OptionableOptionable Beta0.23 Social Links Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.Get This Free Report This page (NASDAQ:CME) was last updated on 5/24/2026 by MarketBeat.com Staff. From Our PartnersHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredYour computer is about to become a museum pieceFuturist George Gilder - who predicted the smartphone years before the iPhone launched - believes today's AI d...Eagle Publishing | SponsoredFrom the man who predicted 2008 crash…Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...Porter & Company | SponsoredSpaceX just filed. The clock is ticking.SpaceX's IPO filing is now public, with a valuation nearing $1.5 trillion - but hedge funds, Goldman partners,...The Oxford Club | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredI was right about SpaceXJeff Brown predicted Bitcoin before it climbed as high as 52,400%, Tesla before 2,150%, and Nvidia before 32,0...Brownstone Research | SponsoredThe S-1 just dropped. 22 days left.The SpaceX S-1 is now public - $18.7 billion in revenue, a $75 billion raise, and a June 12 Nasdaq listing con...Behind the Markets | SponsoredPH: Do THESE 4 things to your bank account now …In a few short months, the US government could gain unprecedented powers over personal bank accounts - includi...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CME Group Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CME Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
